Literature DB >> 24758780

Reconstruction of the Medial Patellofemoral Ligament: Clinical Outcomes and Return to Sports.

Sabine Lippacher1, Jens Dreyhaupt2, Sean R M Williams3, Heiko Reichel4, Manfred Nelitz4.   

Abstract

BACKGROUND: Recent studies have shown that medial patellofemoral ligament (MPFL) reconstruction using a standardized technique provides significant improvements in all outcome scoring systems, with low complication rates and good patient satisfaction. Although numerous studies have assessed clinical results, there is little published literature investigating return to sporting activities after reconstruction of the MPFL.
PURPOSE: To demonstrate postoperative outcomes and the return-to-sports rate a minimum of 2 years after isolated MPFL reconstruction in a young patient cohort. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: Between 2007 and 2010, a total of 72 isolated MPFL reconstructions (in 68 patients) were performed for recurrent patellar dislocation. Pre- and postoperative knee assessment included a thorough history of symptoms and a clinical examination consisting of crepitus, range of motion, patellofemoral pain, and patellar apprehension. Knee function was assessed using the Kujala score, International Knee Documentation Committee score, Tegner activity score, visual analog scale (VAS), and Activity Rating Scale (ARS).
RESULTS: Of patients who participated in sports preoperatively (62/68 patients), 100% returned to sports after MPFL reconstruction; 53% returned at equal or higher levels, whereas 47% returned at lower levels. Fifty-four of 68 patients (79.4%) rated themselves as very satisfied or satisfied with the results. The median Kujala score improved significantly from 66 to 87.5 and the median International Knee Documentation Committee score from 60 to 79.8. The median VAS for pain score illustrated significant preoperative to postoperative improvement, from 4 to 2. Conversely, patients' activity levels according to the Tegner activity score dropped from 4.5 to 4, and the median Activity Rating Scale score dropped from 6 to 3. There was also a persistent instability rate of 10% as well as a slight loss of knee flexion in 24 of 72 knees.
CONCLUSION: Reconstruction of the MPFL is a safe and effective treatment for patellofemoral instability without severe trochlear dysplasia and allows most patients to engage in regular sports activities 2 years postoperatively, at least at a recreational level. However, potential complications, such as persistent instability, pain, and loss of flexion, must be considered.
© 2014 The Author(s).

Entities:  

Keywords:  MPFL; patellofemoral instability; return to sports

Mesh:

Year:  2014        PMID: 24758780     DOI: 10.1177/0363546514529640

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  43 in total

1.  Biomechanical evaluation of MPFL reconstructions: differences in dynamic contact pressure between gracilis and fascia lata graft.

Authors:  Olaf Lorbach; Alexander Haupert; Turgay Efe; Antonius Pizanis; Imke Weyers; Dieter Kohn; Matthias Kieb
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-01-28       Impact factor: 4.342

2.  Repair of the medial patellofemoral ligament with suture tape augmentation leads to similar primary contact pressures and joint kinematics like reconstruction with a tendon graft: a biomechanical comparison.

Authors:  Julian Mehl; Alexander Otto; Brendan Comer; Cameron Kia; Franz Liska; Elifho Obopilwe; Knut Beitzel; Andreas B Imhoff; John P Fulkerson; Florian B Imhoff
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-08-13       Impact factor: 4.342

3.  Surgical management for recurrent patellar dislocations in skeletally immature patients.

Authors:  Filippo Migliorini; Björn Rath; Markus Tingart; Nadine Meisen; Jörg Eschweiler
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-06-29

4.  REHABILITATION FOLLOWING MEDIAL PATELLOFEMORAL LIGAMENT RECONSTRUCTION FOR PATELLAR INSTABILITY.

Authors:  Robert C Manske; Daniel Prohaska
Journal:  Int J Sports Phys Ther       Date:  2017-06

5.  Clinical outcome in MPFL reconstruction with and without tuberositas transposition.

Authors:  A Mulliez; D Lambrecht; D Verbruggen; C Van Der Straeten; P Verdonk; J Victor
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-06-02       Impact factor: 4.342

6.  Visual-palpatory versus fluoroscopic intraoperative determination of the femoral entry point in medial patellofemoral ligament reconstruction.

Authors:  R Herschel; A Hasler; P M Tscholl; S F Fucentese
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-03-12       Impact factor: 4.342

7.  MPFL graft fixation in low degrees of knee flexion minimizes errors made in the femoral location.

Authors:  M Tyrrell Burrus; Brian C Werner; Jourdan M Cancienne; F Winston Gwathmey; David R Diduch
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-16       Impact factor: 4.342

8.  Knee biomechanics during walking in recurrent lateral patellar dislocation are normalized by 1 year after medial patellofemoral ligament reconstruction.

Authors:  Makoto Asaeda; Masataka Deie; Naoto Fujita; Noboru Shimada; Naoya Orita; Daisuke Iwaki; Yoshifumi Kono; Chiaki Terai; Mitsuo Ochi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-02-11       Impact factor: 4.342

9.  Allowing one quadrant of patellar lateral translation during medial patellofemoral ligament reconstruction successfully limits maltracking without overconstraining the patella.

Authors:  John J Elias; Kerwyn C Jones; Molly K Lalonde; Joseph N Gabra; S Cyrus Rezvanifar; Andrew J Cosgarea
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-11       Impact factor: 4.342

10.  Dynamic tracking influenced by anatomy following medial patellofemoral ligament reconstruction: Computational simulation.

Authors:  John J Elias; Kerwyn C Jones; S Cyrus Rezvanifar; Joseph N Gabra; Melanie A Morscher; Andrew J Cosgarea
Journal:  Knee       Date:  2018-03-13       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.